Jeong, B., & Um, S. (2018). First-line osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer. Ann Transl Med.
Citação norma ChicagoJeong, Byeong-Ho, and Sang-Won Um. "First-line Osimertinib in Patients With EGFR-mutated Advanced Non-small Cell Lung Cancer." Ann Transl Med 2018.
MLA CitationJeong, Byeong-Ho, and Sang-Won Um. "First-line Osimertinib in Patients With EGFR-mutated Advanced Non-small Cell Lung Cancer." Ann Transl Med 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.